Skip to content
OpenCapital
Get started

Avanos Medical AVNS Surgical pain and recovery — Net Sales

Other product segments

Enteral feeding
$84.6M+13.6%
Neonate solutions
$39.4M+48.1%
Radiofrequency ablation
$34.5M+8.8%

Similar metrics at other companies

Enovis logo
ENOVSurgical — Net Sales
$317.13M+10.8%
TFX
TFXSurgical — Net revenues
$106.79M+12.4%
Medline, Inc. logo
MDLNSurgical Solutions — Net Sales
$1.55B+7.4%
Edwards Lifesciences logo
EWSurgical — Net Sales
$276.2M+10.1%
The Cooper Companies, Inc. logo
COOOffice and surgical — Net Sales
$214.2M+4.1%
Baxter International logo
BAXAdvanced Surgery — Net Sales
$304M+13.4%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's surgical pain and recovery — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's surgical pain and recovery — net sales?
Avanos Medical (AVNS) reported surgical pain and recovery — net sales of $21.8M in Q1 2026.
How has Avanos Medical's surgical pain and recovery — net sales changed year-over-year?
Avanos Medical's surgical pain and recovery — net sales decreased by 11.0% year-over-year, from $24.5M to $21.8M.
What is the long-term trend for Avanos Medical's surgical pain and recovery — net sales?
Over 4 years (2021 to 2025), Avanos Medical's surgical pain and recovery — net sales has grown at a -11.7% compound annual growth rate (CAGR), from $162.7M to $98.8M.
What does surgical pain and recovery — net sales mean?
This metric represents the total revenue generated from the sale of products within the surgical pain and recovery business unit. It reflects the market demand and commercial performance of medical devices designed to assist in post-operative pain management and patient recovery. Monitoring this figure helps investors assess the growth trajectory and competitive positioning of the company's specialized surgical portfolio.